{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:49:46Z","timestamp":1773312586321,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01622-5","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:13:30Z","timestamp":1740222810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Is it time to abandon staging surgery and prolonged follow-up in patients with primary adult-type granulosa cell tumor?"],"prefix":"10.1186","volume":"18","author":[{"given":"Geertruid J.","family":"Brink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolijn W.","family":"Groeneweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane A.","family":"Sickinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans W.","family":"Nijman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc R.C.W.","family":"van Lonkhuijzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christianne A. R.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurgen M. J.","family":"Piek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Maria","family":"Roes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis D.","family":"de Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ward","family":"Hofhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertruida N.","family":"Jonges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eelke H.","family":"Gort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petronella O.","family":"Witteveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald P.","family":"Zweemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"issue":"2","key":"1622_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ygyno.2011.10.015","volume":"124","author":"H-D Sun","year":"2012","unstructured":"Sun H-D, et al. A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol. 2012;124(2):244\u20139.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"1622_CR2","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1200\/JCO.2003.10.019","volume":"21","author":"ST Schumer","year":"2003","unstructured":"Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21(6):1180\u20139.","journal-title":"J Clin Oncol"},{"key":"1622_CR3","unstructured":"Ferlay J, Lam EM, Laversanne F, Colombet M, Mery M, Pi\u00f1eros L, Znaor M, Soerjomataram A, Bray I. F. Global Cancer Observatory: Cancer Today.. 2024 11 June 2024]; Available from: https:\/\/gco.iarc.who.int\/today"},{"key":"1622_CR4","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/annonc\/mdy001","volume":"29","author":"I Ray-Coquard","year":"2018","unstructured":"Ray-Coquard I, et al. Non-epithelial ovarian cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv1\u201318.","journal-title":"Ann Oncol"},{"key":"1622_CR5","unstructured":"Integraal K, Nederland WOG. Niet epitheliale maligniteiten van het ovarium. Landelijke richtlijn, versie: 2.0. 2016; Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/niet_epitheliale_maligniteiten_ovarium\/algemeen.html"},{"issue":"8","key":"1622_CR6","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1097\/IGC.0b013e3182a57fb4","volume":"23","author":"HS van Meurs","year":"2013","unstructured":"van Meurs HS, et al. The incidence of endometrial hyperplasia and cancer in 1031 patients with a granulosa cell tumor of the ovary: long-term follow-up in a population-based cohort study. Int J Gynecol Cancer. 2013;23(8):1417\u201322.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1622_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ygyno.2011.12.442","volume":"125","author":"JY Park","year":"2012","unstructured":"Park JY, et al. Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol. 2012;125(1):80\u20136.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1622_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ygyno.2014.01.011","volume":"133","author":"M Kleppe","year":"2014","unstructured":"Kleppe M, et al. Lymph-node metastasis in stage I and II sex cord stromal and malignant germ cell tumours of the ovary: a systematic review. Gynecol Oncol. 2014;133(1):124\u20137.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1622_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/IGC.0000000000000304","volume":"25","author":"S Bryk","year":"2015","unstructured":"Bryk S, et al. Clinical characteristics and survival of patients with an adult-type ovarian granulosa cell tumor: a 56-Year single-center experience. Int J Gynecologic Cancer. 2015;25(1):33\u201341.","journal-title":"Int J Gynecologic Cancer"},{"issue":"1","key":"1622_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/bjc.2013.241","volume":"109","author":"G Mangili","year":"2013","unstructured":"Mangili G, et al. Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. Br J Cancer. 2013;109(1):29\u201334.","journal-title":"Br J Cancer"},{"key":"1622_CR11","doi-asserted-by":"crossref","unstructured":"McConechy MK et al. Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype. JNCI: Journal of the National Cancer Institute, 2016. 108(11).","DOI":"10.1093\/jnci\/djw134"},{"issue":"2","key":"1622_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ygyno.2015.05.011","volume":"138","author":"MK Wilson","year":"2015","unstructured":"Wilson MK, et al. Stage I granulosa cell tumours: a management conundrum? Results of long-term follow up. Gynecol Oncol. 2015;138(2):285\u201391.","journal-title":"Gynecol Oncol"},{"key":"1622_CR13","unstructured":"Plett H et al. Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence. Int J Gynecologic Cancer, 2023;33(5)."},{"issue":"1","key":"1622_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000274590","volume":"3","author":"D Teoh","year":"2010","unstructured":"Teoh D, Freedman R, Soliman PT. Nearly 30 years of treatment for recurrent Granulosa Cell Tumor of the Ovary: a Case Report and Review of the literature. Case Rep Oncol. 2010;3(1):14\u20138.","journal-title":"Case Rep Oncol"},{"issue":"12","key":"1622_CR15","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.3390\/cancers14122998","volume":"14","author":"GJ Brink","year":"2022","unstructured":"Brink GJ, et al. Response to systemic therapies in ovarian adult granulosa cell tumors: a literature review. Cancers. 2022;14(12):2998.","journal-title":"Cancers"},{"key":"1622_CR16","unstructured":"Castor EDC. Castor Electronic Data Capture. 2019 August 28, 2019]; Available from: https:\/\/castoredc.com"},{"key":"1622_CR17","unstructured":"Julius. Clinical. Available from: https:\/\/www.juliusclinical.com\/"},{"key":"1622_CR18","unstructured":"GraphPad P. 2023, GraphPad Software, Boston, Massachusetts USA."},{"issue":"2","key":"1622_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"key":"1622_CR20","unstructured":"Dutch Cancer Registry I. Available from: nkr-cijfers.iknl.nl."},{"key":"1622_CR21","doi-asserted-by":"crossref","unstructured":"Portuesi R et al. Role of inhibin B in detecting recurrence of granulosa cell tumors of the ovary in postmenopausal patients. Int J Gynecologic Cancer, 2021;31(6).","DOI":"10.1136\/ijgc-2020-002205"},{"issue":"14","key":"1622_CR22","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1002\/cncr.34767","volume":"129","author":"VM White","year":"2023","unstructured":"White VM, et al. How social media can help to understand treatment experiences of survivors of rare cancers: findings from the Granulosa Cell Tumor Survivor Sisters Facebook group member survey. Cancer. 2023;129(14):2224\u201334.","journal-title":"Cancer"},{"key":"1622_CR23","doi-asserted-by":"crossref","unstructured":"Newton C et al. British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU). Int J Gynecologic Cancer, 2020;30(5).","DOI":"10.1136\/ijgc-2019-001176"},{"issue":"4","key":"1622_CR24","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.3390\/curroncol30040276","volume":"30","author":"HM Luk","year":"2023","unstructured":"Luk HM, et al. Patient-initiated Follow-Up in Ovarian Cancer. Curr Oncol. 2023;30(4):3627\u201336.","journal-title":"Curr Oncol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01622-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01622-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01622-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:13:35Z","timestamp":1740222815000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01622-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01622-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A national multicenter prospective study was conducted and approved by the Medical Ethics Committee of the University Medical Centre Utrecht (UMCU METC 17\u2013868) and by the institutional review boards of all participating centers. All patients provided written informed consent. The study was registered in the Dutch Trial Register under trial number NL63786.041.17, first registered on April 17, 2018 (). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.M.J. Piek received grants of the Dutch Cancer society, the Catharina research fund and the INNOsign\/OPZuid grant. C.D. de Kroon received grants from ZonMW, KWF, and ZorgInstituut, and occupies chair roles for the guideline committee on endometrial cancer and the working party gynecological oncology from the NVOG. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}